Drug Profile
Research programme: mTOR protein modulators - Mount Tam Biotechnologies/University of Chile
Alternative Names: mTOR protein modulators- Mount Tam Biotechnologies/University of ChileLatest Information Update: 28 Aug 2021
Price :
$50
*
At a glance
- Originator Mount Tam Biotechnologies
- Developer Mount Tam Biotechnologies; University of Chile
- Class Antiparkinsonians
- Mechanism of Action MTOR protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for preclinical development in Parkinson's-disease in Chile
- 28 Aug 2021 No recent reports of development identified for preclinical development in Parkinson's-disease in USA
- 27 Jul 2017 Mount Tam Biotechnologies and University of Chile agree to develop mTOR modulators in Chile and USA for Parkinson's disease